Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Trading Statement

31 Jan 2019 07:00

RNS Number : 5883O
Dairy Crest Group PLC
31 January 2019
 

31 January 2019

 

Dairy Crest Group plc ("Dairy Crest")

 

Trading Update

Strong Third Quarter; Full Year In Line With Expectations

 

Dairy Crest is today issuing a Trading Update for the nine months ended 31 December 2018.

 

The company's key brands - Cathedral City, Clover, Country Life and Frylight - all delivered strong volume and revenue growth for the third quarter ended 31 December 2018. On a combined basis, the four brands generated revenue growth of around 10% for the third quarter and 6% for the nine months ended 31 December 2018.

 

In line with our expectations at the time of the Interim Results, Cathedral City had a particularly good third quarter. Both volume and revenue grew by around 10%, helped in part by new product launches, including flavoured snack bars, Lactose Free and a refreshed kids' snacking range.

 

Dairy Crest's spreads brands continue to gain market share. Clover Light with no artificial ingredients was launched in August 2018 and has been voted 'Product of the Year' in the UK spreads category in the world's largest consumer survey for product innovation.

 

Frylight returned to double digit volume and revenue growth in the third quarter, although over the nine month period the brand declined due to the challenging first half of the year.

 

Following a reduction in cream prices, we started to promote Country Life again which led to positive volume and revenue growth in the quarter. The partnership with English Heritage offering 2 for 1 entry began this month.

 

Demand for our functional ingredients - demineralised whey powder and galacto-oligosaccharides (GOS) - continues to increase. In January 2019, daily Promovita GOS 'shots' for consumers went on sale for the first time.

  

There is significant uncertainty around Brexit and the impact of a potentially disorderly exit is hard to predict. Whilst our supply chain and customer base are primarily located in the UK, we are taking steps to reduce our exposure, including accelerating the purchase of ingredients and packaging materials.

 

Notwithstanding this, the outlook for the full year remains in line with our expectations.

 

Mark Allen, Chief Executive of Dairy Crest, commented:

"Our key brands have delivered exceptional performance in the third quarter with all four generating both volume and revenue growth. Demand for our functional ingredients is also increasing, with positive implications for price.

 

"We have launched several major innovations during the past nine months. It is gratifying to have received external validation of one our most technologically advanced achievements, Clover Light with No Artificial Ingredients, by winning 'Product of the Year 2019'. This is the third consecutive year that one of our products has been awarded this accolade."

 

Dairy Crest will issue its Preliminary Results for the year ended 31 March 2019 on23 May 2019.

 

For further information:

Investors/Analysts

 

 

 

Tom Atherton

 

Dairy Crest

01372 472264

Kate Goode

 

Dairy Crest

01372 472236

 

 

 

 

Media

 

 

 

Tim Danaher/Alison Lea

Brunswick

020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFFRLTIIVIA
Date   Source Headline
19th Mar 20083:00 pmRNSMerger Update
11th Mar 20089:25 amRNSAdditional Listing
5th Mar 20086:02 pmRNSTotal Voting Rights
12th Feb 20081:28 pmRNSDirector/PDMR Shareholding
11th Feb 20085:02 pmRNSTotal Voting Rights
29th Jan 20087:00 amRNSInterim Management Statement
25th Jan 20089:33 amRNSHolding(s) in Company
14th Jan 200810:41 amRNSHolding(s) in Company
7th Jan 20082:27 pmRNSDirector/PDMR Shareholding
2nd Jan 200812:55 pmRNSHolding(s) in Company
17th Dec 20079:09 amRNSDirector/PDMR Shareholding
14th Dec 20073:17 pmRNSHolding(s) in Company
13th Dec 20075:32 pmRNSHolding(s) in Company
11th Dec 20074:43 pmRNSHolding(s) in Company
7th Dec 20075:00 pmRNSHolding(s) in Company
7th Dec 20077:19 amRNSOFT EARLY SETTLEMENT IN DAIRY
7th Dec 20077:14 amRNSResponse to OFT
28th Nov 200710:31 amRNSAppointment
15th Nov 200712:53 pmRNSHolding(s) in Company
8th Nov 20077:02 amRNSInterim Results
30th Oct 20074:43 pmRNSHolding(s) in Company
1st Oct 200710:46 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSTrading Update
20th Sep 200711:53 amRNSResponse to OFT Statement
28th Aug 20079:57 amRNSDirector/PDMR Shareholding
24th Aug 20074:01 pmRNSHolding(s) in Company
20th Aug 20074:01 pmRNSHolding(s) in Company
15th Aug 20072:32 pmRNSHolding(s) in Company
15th Aug 20072:25 pmRNSHolding(s) in Company
19th Jul 20077:00 amRNSIMS and Appointments
9th Jul 200711:45 amRNSHolding(s) in Company
9th Jul 20079:07 amRNSTotal Voting Rights
5th Jul 200712:23 pmRNSHolding(s) in Company
2nd Jul 200710:48 amRNSDirector/PDMR Shareholding
22nd Jun 200712:56 pmRNSDirector/PDMR Shareholding
19th Jun 20072:27 pmRNSDirector/PDMR Shareholding
5th Jun 20078:00 amRNSNon-executive Director
29th May 20077:03 amRNSClover product recall notice
22nd May 200712:37 pmRNSDividend
22nd May 20077:03 amRNSPreliminary Results
14th May 200710:00 amRNSPotential closure of site
10th Apr 200712:35 pmRNSTotal Voting Rights
26th Mar 20077:00 amRNSPre-close Trading Update
2nd Mar 200712:32 pmRNSDirector/PDMR Shareholding
15th Feb 20075:45 pmRNSHolding(s) in Company
15th Feb 20074:48 pmRNSDirector/PDMR Shareholding
26th Jan 20077:01 amRNSAppointment
24th Jan 20072:36 pmRNSDirector Declaration
22nd Jan 200710:54 amRNSTotal Voting Rights
16th Jan 200712:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.